| scholarly article | Q13442814 |
| P50 | author | H. Julia Hannay | Q42725599 |
| Julia S Benoit | Q56883913 | ||
| Lucia Rivera-Lara | Q57756325 | ||
| P2093 | author name string | Claudia S Robertson | |
| Osama Ahmed | |||
| Paul Swank | |||
| Alex Valadka | |||
| José-Miguel Yamal | |||
| Barbara C Tilley | |||
| J Clay Goodman | |||
| Pratik Doshi | |||
| Imoigele P Aisiku | |||
| Shankar Gopinath | |||
| Santhosh Sadasivan | |||
| Hazem Shahin | |||
| Hector Saucedo-Crespo | |||
| M Laura Rubin | |||
| Leslie Neipert | |||
| Athena Baldwin | |||
| Epo Severe TBI Trial Investigators | |||
| Jace M Waguspack | |||
| Jovanny Cruz-Navarro | |||
| Luciano Ponce | |||
| P2860 | cites work | Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress | Q24611053 |
| The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care | Q28245876 | ||
| THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL | Q29038535 | ||
| A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group | Q29620037 | ||
| Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs | Q30810700 | ||
| Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. | Q33358264 | ||
| Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats | Q35194540 | ||
| Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy | Q36126534 | ||
| Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis | Q36371706 | ||
| Effect of erythropoietin on Glasgow Coma Scale and Glasgow Outcome Sale in patient with diffuse axonal injury | Q36470042 | ||
| Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury | Q37250532 | ||
| Transfusion of red blood cells in patients with a prehospital Glasgow Coma Scale score of 8 or less and no evidence of shock is associated with worse outcomes. | Q37310027 | ||
| Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: effect of availability of exception from informed consent | Q37681891 | ||
| Transfusions and long-term functional outcomes in traumatic brain injury | Q37683758 | ||
| Recombinant human erythropoietin in the treatment of acute ischemic stroke | Q38378327 | ||
| Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial | Q38498896 | ||
| Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee | Q40662879 | ||
| Safety and Efficacy of Erythropoietin in Traumatic Brain Injury Patients: A Pilot Randomized Trial | Q42413212 | ||
| Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: comparison of treatment with single and triple dose | Q42737005 | ||
| Erythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control study | Q44213738 | ||
| The diagnosis of head injury requires a classification based on computed axial tomography | Q44489764 | ||
| Transfusion practices for acute traumatic brain injury: a survey of physicians at US trauma centers | Q44802066 | ||
| The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury | Q45204432 | ||
| Low hematocrit levels increase intracranial pressure in an animal model of cryogenic brain injury | Q46092807 | ||
| The effect of blood transfusion on brain oxygenation in children with severe traumatic brain injury | Q46465723 | ||
| Prediction of outcome in traumatic brain injury with computed tomographic characteristics: a comparison between the computed tomographic classification and combinations of computed tomographic predictors | Q46838100 | ||
| Guidelines for the management of severe traumatic brain injury | Q48163575 | ||
| Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats | Q48182845 | ||
| Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. | Q48401602 | ||
| Effect of a liberal versus restrictive transfusion strategy on mortality in patients with moderate to severe head injury | Q48425902 | ||
| Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study | Q48606982 | ||
| Transfusion strategies for patients in pediatric intensive care units. | Q50698283 | ||
| Improved survival of critically ill trauma patients treated with recombinant human erythropoietin | Q81770219 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | erythropoietin | Q218706 |
| traumatic brain injury | Q1995526 | ||
| P304 | page(s) | 36-47 | |
| P577 | publication date | 2014-07-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial | |
| P478 | volume | 312 |
| Q38681722 | A State-of-the-Science Overview of Randomized Controlled Trials Evaluating Acute Management of Moderate-to-Severe Traumatic Brain Injury. |
| Q38684753 | A joint logistic regression and covariate-adjusted continuous-time Markov chain model. |
| Q90327613 | A meta-analysis and systematic review evaluating the use of erythropoietin in total hip and knee arthroplasty |
| Q35192848 | ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. |
| Q47755572 | Acute Management of Traumatic Brain Injury |
| Q38790372 | Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain Injury |
| Q49375977 | Alternative Erythropoietin Receptors in the Nervous System |
| Q36269794 | Anemia and Blood Transfusion in Patients with Isolated Traumatic Brain Injury |
| Q26745655 | Anemia management after acute brain injury |
| Q40721720 | Association Between Relative Anemia and Early Functional Recovery After Severe Traumatic Brain Injury (TBI). |
| Q48036890 | Association between delivery methods for red blood cell transfusion and the risk of venous thromboembolism: a longitudinal study |
| Q36210438 | Association of transfusion red blood cell storage age and blood oxygenation, long-term neurologic outcome, and mortality in traumatic brain injury |
| Q39948879 | Beneficial Effect of Erythropoietin Short Peptide on Acute Traumatic Brain Injury |
| Q92727799 | Benefits of red blood cell transfusion in patients with traumatic brain injury |
| Q38774608 | Beta-Blockers and Traumatic Brain Injury: A Systematic Review, Meta-analysis, and Eastern Association for the Surgery of Trauma Guideline |
| Q39890311 | Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy |
| Q38298655 | Blood transfusion practices in neuroanaesthesia |
| Q42722918 | Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models |
| Q36001623 | Causal Structure of Brain Physiology after Brain Injury from Subarachnoid Hemorrhage |
| Q40002588 | Cerebral Microcirculation during Experimental Normovolaemic Anemia |
| Q36791150 | Charting a course for erythropoietin in traumatic brain injury. |
| Q39443587 | Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management |
| Q49017368 | Determinants of red blood cell transfusion in pediatric trauma patients admitted to the intensive care unit. |
| Q90611230 | Discharge Hemoglobin Level and 30-Day Readmission Rates After Coronary Artery Bypass Surgery |
| Q100395179 | Drugs with anti-inflammatory effects to improve outcome of traumatic brain injury: a meta-analysis |
| Q50076601 | EPO improved neurologic outcome in rat pups late after traumatic brain injury |
| Q47641132 | EPO in traumatic brain injury: two strikes…but not out? |
| Q92537464 | Editorial: Developing Successful Neuroprotective Treatments for TBI: Translational Approaches, Novel Directions, Opportunities and Challenges |
| Q35941906 | Effect of Hemoglobin Transfusion Threshold on Cerebral Hemodynamics and Oxygenation |
| Q26749482 | Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis |
| Q42276992 | Effects of Quercetin and Mannitol on Erythropoietin Levels in Rats Following Acute Severe Traumatic Brain Injury |
| Q50277067 | Effects of Red Blood Cell Transfusion on Long-Term Disability of Patients with Traumatic Brain Injury. |
| Q57155530 | Electrophysiological Signature Reveals Laminar Structure of the Porcine Hippocampus |
| Q41908695 | Embracing Biological and Methodological Variance in a New Approach to Pre-Clinical Stroke Testing |
| Q28087789 | Emerging therapies in traumatic brain injury |
| Q47911477 | Encouraging single-unit transfusions: a superior patient blood management strategy? |
| Q36246631 | Erythropoiesis stimulating agents and reno-protection: a meta-analysis |
| Q28066377 | Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy |
| Q48140419 | Erythropoietin in Traumatic Brain Injury: An Answer Will Come Soon |
| Q47806649 | Erythropoietin in diabetic retinopathy. |
| Q40447654 | Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial. |
| Q47156500 | Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury. |
| Q39385930 | Evaluation of RBC Transfusion Practice in Adult ICUs and the Effect of Restrictive Transfusion Protocols on Routine Care |
| Q34670021 | Evidence base for restrictive transfusion triggers in high-risk patients |
| Q48042344 | Evidence-based medicine: Save blood, save lives |
| Q28079256 | Evidence-based review of oral traditional Chinese medicine compound recipe administration for treating weight drop-induced experimental traumatic brain injury |
| Q55413545 | Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats. |
| Q46451320 | FGF2 Attenuates Neural Cell Death via Suppressing Autophagy after Rat Mild Traumatic Brain Injury. |
| Q48251901 | Focus on clinical neuroscience |
| Q64111398 | Glasgow Outcome Scale Measures and Impact on Analysis and Results of a Randomized Clinical Trial of Severe Traumatic Brain Injury |
| Q38608377 | Harms of off-label erythropoiesis-stimulating agents for critically ill people |
| Q41686292 | Hemoglobin Area and Time Index Above 90 g/L are Associated with Improved 6-Month Functional Outcomes in Patients with Severe Traumatic Brain Injury |
| Q33808430 | Hemoglobin concentrations and RBC transfusion thresholds in patients with acute brain injury: an international survey |
| Q41193822 | Higher haemoglobin levels and dedicated trauma admission are associated with survival after severe traumatic brain injury. |
| Q37724782 | Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury. |
| Q26752496 | Impact of Transfusion on Cancer Growth and Outcome |
| Q39356470 | Impact of red blood cell transfusion strategies in haemato-oncological patients: a systematic review and meta-analysis. |
| Q38875861 | Implementation of Neurocritical Care Is Associated With Improved Outcomes in Traumatic Brain Injury |
| Q26992292 | Indications for blood and blood product transfusion |
| Q88720568 | Indications for red cell transfusions in pediatric patients |
| Q35611476 | Investigational agents for treatment of traumatic brain injury |
| Q42762679 | Is erythropoietin a worthy candidate for traumatic brain injury or are we heading the wrong way? |
| Q89581411 | Is haemoglobin below 7.0 g/dL an optimal trigger for allogenic red blood cell transfusion in patients admitted to intensive care units? A meta-analysis and systematic review |
| Q64080372 | Longitudinal Changes in Disability Rating Scale Scores: A Secondary Analysis Among Patients With Severe TBI Enrolled in the Epo Clinical Trial |
| Q47237235 | MCC950, the selective NLRP3 inflammasome inhibitor protects mice against traumatic brain injury |
| Q39345424 | Medical Management of the Severe Traumatic Brain Injury Patient |
| Q95820947 | Meta-analysis with Trial Sequential Analysis on the Efficacy and Safety of Erythropoietin in Traumatic Brain Injury: A New Paradigm |
| Q89866105 | MicroRNA sequencing of rat hippocampus and human biofluids identifies acute, chronic, focal and diffuse traumatic brain injuries |
| Q38388853 | Molecular mechanisms of erythrocyte aging |
| Q57170404 | Multi-Center Pre-clinical Consortia to Enhance Translation of Therapies and Biomarkers for Traumatic Brain Injury: Operation Brain Trauma Therapy and Beyond |
| Q58566923 | Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials |
| Q35503413 | Neuroprotection in acute brain injury: an up-to-date review |
| Q92964494 | Neurotherapeutic potential of erythropoietin after ischemic injury of the central nervous system |
| Q48142126 | Non-invasive diagnosis and treatment strategies for traumatic brain injury: an update |
| Q90301369 | Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh Vision |
| Q28647190 | Patient blood management: it is time to streamline targeted therapy options |
| Q55059568 | Patient blood management: where's the bottom? |
| Q39008879 | Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides |
| Q36060634 | Pharmacologic Neuroprotection for Functional Outcomes After Traumatic Brain Injury: A Systematic Review of the Clinical Literature |
| Q90197287 | Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats |
| Q37258111 | Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury |
| Q61812558 | Prehospital and Emergency Care in Adult Patients with Acute Traumatic Brain Injury |
| Q64113696 | Prognosis of Six-Month Glasgow Outcome Scale in Severe Traumatic Brain Injury Using Hospital Admission Characteristics, Injury Severity Characteristics, and Physiological Monitoring during the First Day Post-Injury |
| Q39947681 | Progressive hemorrhagic injury after severe traumatic brain injury: effect of hemoglobin transfusion thresholds |
| Q46172024 | Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury. |
| Q92145307 | Public Approval of Exception From Informed Consent in Emergency Clinical Trials: A Systematic Review of Community Consultation Surveys |
| Q53567876 | Pyruvate Is Superior to Citrate in Oral Rehydration Solution in the Protection of Intestine via Hypoxia-Inducible Factor-1 Activation in Rats With Burn Injury. |
| Q36750167 | Recent Advances in Preventing Adverse Reactions to Transfusion |
| Q40607264 | Red Cell Transfusion Triggers and Postoperative Outcomes After Major Surgery. |
| Q50245118 | Red blood cells stored 35 days or more are associated with adverse outcomes in high-risk patients |
| Q54838335 | Red cell transfusion in the critically ill patient. |
| Q36247651 | Regeneration in the nervous system with erythropoietin |
| Q39627599 | Relative impact of a patient blood management program on utilization of all three major blood components |
| Q49795224 | Reproducibility of clinical research in critical care: a scoping review |
| Q30238759 | Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support. |
| Q38389607 | Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis |
| Q39306479 | Severe traumatic brain injury: targeted management in the intensive care unit. |
| Q47226017 | Should Transfusion Trigger Thresholds Differ for Critical Care Versus Perioperative Patients? A Meta-Analysis of Randomized Trials |
| Q43973725 | Should red blood cell transfusion be individualized? No. |
| Q38977560 | Single-unit transfusions and hemoglobin trigger: relative impact on red cell utilization |
| Q47679937 | TBI-the most complex disease in the most complex organ: the CENTER-TBI trial-a commentary |
| Q42339639 | Targeted therapeutic mild hypercapnia after cardiac arrest. |
| Q48219974 | The Effect of Red Blood Cell Transfusion on Cerebral Autoregulation in Patients with Severe Traumatic Brain Injury |
| Q64111058 | The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition |
| Q27339343 | The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition |
| Q39963920 | The Negative Impact of Anemia in Outcome from Traumatic Brain Injury |
| Q86274178 | The Rheology of Subarachnoid Hemorrhage |
| Q55426553 | The currency, completeness and quality of systematic reviews of acute management of moderate to severe traumatic brain injury: A comprehensive evidence map. |
| Q58581801 | The effects of normovolemic anemia and blood transfusion on cerebral microcirculation after severe head injury |
| Q30235977 | The far-reaching scope of neuroinflammation after traumatic brain injury |
| Q36515525 | The incidence of ARDS and associated mortality in severe TBI using the Berlin definition |
| Q57152125 | Therapeutic hypothermia and targeted temperature management for traumatic brain injury: Experimental and clinical experience |
| Q36909393 | Therapeutic hypothermia and targeted temperature management in traumatic brain injury: Clinical challenges for successful translation |
| Q38687477 | Thrombotic and Infectious Morbidity Are Associated with Transfusion in Posterior Spine Fusion |
| Q64319043 | Transfusion Practices Among General Surgeons at a Tertiary Care Center: a Survey Based Study |
| Q48733691 | Transfusion in Traumatic Brain Injury |
| Q37728294 | Transfusion of red blood cells in patients with traumatic brain injuries admitted to Canadian trauma health centres: a multicentre cohort study |
| Q47840505 | Transfusion practices in traumatic brain injury |
| Q64101807 | Transfusion requirements after head trauma: a randomized feasibility controlled trial |
| Q30243882 | Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. |
| Q38315925 | Traumatic brain injury in 2014. Progress, failures and new approaches for TBI research |
| Q38678261 | Traumatic brain injury research highlights in 2015. |
| Q38538072 | Treatment of traumatic brain injury with anti-inflammatory drugs. |
| Q47944945 | Treatment options for severe traumatic brain injuries in children: current therapies, challenges, and future prospects |
| Q39061409 | Venous thromboembolic events in critically ill traumatic brain injury patients. |
| Q91671313 | WSES consensus conference guidelines: monitoring and management of severe adult traumatic brain injury patients with polytrauma in the first 24 hours |
| Q52577003 | [Appropriate use of red blood cell transfusion in the emergency department before and after a specific protocol]. |
| Q53656120 | [Intensive care treatment after aneurysmal subarachnoid hemorrhage]. |
| Q52686811 | [Intensive care treatment of traumatic brain injury in multiple trauma patients : Decision making for complex pathophysiology]. |
Search more.